Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Canada Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20024
20044
20057
20068
20073
20081
20096
20102
20113
20124
20133
20144
20151
20171
20181
20202
20213
20223
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Recruiting5
Terminated5
Unknown status4
Active, not recruiting3
No longer available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals20
Bristol-Myers Squibb7
University Health Network, Toronto5
Pfizer4
Astex Pharmaceuticals, Inc.3
National Cancer Institute (NCI)3
Ascentage Pharma Group Inc.2
Teva Branded Pharmaceutical Products R&D, Inc.2
University of Milano Bicocca2
Accenture1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive66
Precursor Cell Lymphoblastic Leukemia-Lymphoma15
Leukemia14
Blast Crisis12
Myeloproliferative Disorders7
Leukemia, Myeloid6
Leukemia, Myeloid, Chronic-Phase6
Hematologic Neoplasms5
Leukemia, Myeloid, Acute5
Philadelphia Chromosome5

Trials

Showing 76 to 66 of 66. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.